In a roundtable discussion on metastatic prostate cancer, moderated by Jacob Ark, MD, of Urology of St. Louis, panelists explore key topics, including the definitions and diagnostic criteria for hormone-sensitive and castration-resistant disease, the role of germline and somatic testing, and the integration of precision medicine into clinical practice. The panel shares insights into the latest advancements, including PSMA imaging and genetic testing, highlighting how evolving science is shaping the future of prostate cancer management. ...
Prostate Cancer Diagnostics
Advertisement
Latest News
The FDA's Fast Track Designation enables expedited development of 64Cu-SAR-bisPSMA for recurrent prostate cancer imaging.
Dr. Sanchez-Salas comments on whether PSMA PET is useful for determining optimal candidates for focal therapy.
Dr. Kaouk presented on the benefits of surgery for managing biochemically recurrent prostate cancer post-radiation.
Dr. Thompson, Jr. highlights his recently published large dataset of long-term complications of prostate cancer treatment.
Conventional imaging may understage patients with HR nmHSPC compared to PSMA-PET imaging.
Drs. Saji and Lebastchi explore focal therapy, covering its historical evolution, techniques, and energy modalities.
Advertisement
Prostate Cancer Knowledge Hubs
Curated clinical content on prostate cancer types, therapies, and technologies
Conference Coverage
Dr. Dan Joyce discusses key SUO studies on RCC prognostics, personalized medicine, and advancements in treatment strategies.
Dr. Syan highlights advancements in pelvic medicine and reconstructive surgery, and progress in gender-specific challenges.
Dr. Syan shares her vision for the meeting and the lessons or feedback from the past two years that helped shape the program.
Dr. Sanchez-Salas comments on whether PSMA PET is useful for determining optimal candidates for focal therapy.
Dr. Sanchez-Salas details strategies for selecting between focal therapy versus active surveillance or definitive treatments.
Dr. Kaouk presented on the benefits of surgery for managing biochemically recurrent prostate cancer post-radiation.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.